Davis Andrew S.

Chief Commercial OfficerSilk Road Medical Inc (SILK) · full profile →Form 4 · filed Sep 18, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
3 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 17, 2024Disposed to issuer(D)290K0
Sep 17, 2024Grant(A)42K$042K
Sep 17, 2024Disposed to issuer(D)42K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 17, 2024Disposed to issuer(D)33K$7.50$249K0
Sep 17, 2024Disposed to issuer(D)22K$25.90$571K0
Sep 17, 2024Disposed to issuer(D)63K$22.77$1.4M0
Sep 17, 2024Disposed to issuer(D)2K$21.39$40K0

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-24-041410) within minutes of acceptance. Every field above traces to the original document. Verify it directly: